MedPath

Comparison of Intra Muscular Oxytocin 10 Units Vs Oxytocin 5U plus Ergometrine 0.2mg Vs Carbetocin 100mcg in reduction of Postpartum Blood lossâ?? A Randomized Controlled Trial â??

Phase 1
Conditions
Health Condition 1: O80- Encounter for full-term uncomplicated delivery
Registration Number
CTRI/2023/05/053086
Lead Sponsor
Dr TSaieswari
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1 Singleton live gestation

2 Gestational age between 37 0/7 to 41 6/7

3 After obtaining informed written consent

4 Women admitting in labour ( < 6cm cervical dilatation according to WHO)

Exclusion Criteria

1 Hypertensive disorders of pregnancy

2 Known medical disorders

3 Antepartum haemorrhage

4 Known epileptic patients

5 Known coagulopathies

6 Known hemoglobinopathies

•Placental abnormalities

•Known contraindications to study drugs

•Women who are not willing to consent for the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To determine the effectiveness uterotonic drug (oxytocin or carbetocin or oxytocin + ergometrine) which helps in reducing the post partum blood lossTimepoint: depends on the baby delivery time
Secondary Outcome Measures
NameTimeMethod
â?¢To estimate the proportion of women receiving extra uterotonic drugs <br/ ><br>â?¢Women requiring transfusion of blood or blood products <br/ ><br>â?¢Use of other measures to treat postpartum hemorrhage like examining under anaesthetic care or uterine compression or intra uterine balloon tamponade. <br/ ><br>Timepoint: to estimate within 24 hours
© Copyright 2025. All Rights Reserved by MedPath